Treatments

Treatments

Personalised plans for prime results

Wegovy (semaglutide)

• Weekly GLP 1 agonist; strong efficacy
• Step up dosing to 2.4 mg max

Saxenda (liraglutide)

• Daily injectable GLP 1 for patients preferring non weekly dosing

Mounjaro (tirzepatide)

• Dual GIP/GLP 1 agonist
• Potentially superior efficacy; titration up to 15 mg

Orlistat (Xenical)

• Non injectable option; lipase inhibitor for patients unsuitable for GLP 1s

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s.

Our approach to tackling weight loss

Our approach to tackling weight loss

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged It has survived not only five centuries. electronic typesetting, remaining essentially unchanged It has survived not only five centuries. electronic typesetting, remaining essentially unchanged It has survived not only five centuries. 

Approach 2

Approach 3

Approach 4

Approach 5